What does Ki-67 mean on a pathology report
For informational purposes only
This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.
Understanding Ki-67 on Your Pathology Report
Ki-67 is a protein that measures how fast cancer cells are dividing and growing. Think of it as a "proliferation index" — essentially a snapshot of how active your cancer cells are at the cellular level.
How It Works
When pathologists examine your cancer tissue under a microscope, they use special stains to identify which cells are actively dividing. Ki-67 is a marker that appears in cells that are in the process of reproducing. The pathologist counts what percentage of cancer cells show this marker.
What the Percentage Means
Ki-67 is reported as a percentage (for example, "Ki-67: 20%"):
- Low Ki-67 (typically <10-15%): Cancer cells are dividing slowly — generally associated with slower-growing cancers
- Intermediate Ki-67 (15-30%): Moderate growth rate
- High Ki-67 (>30%): Cancer cells are dividing rapidly — suggests more aggressive behavior
Why Doctors Care About This
According to NCCN Guidelines and ASCO recommendations, Ki-67 helps oncologists:
- Assess how aggressive your cancer is
- Predict how the cancer might behave
- Help guide treatment decisions (particularly in breast cancer, where it influences hormone therapy vs. chemotherapy choices)
- Estimate prognosis alongside other factors
Important Context
Ki-67 is one piece of information among many. Your doctor considers it alongside:
- Tumor grade and stage
- Hormone receptor status (ER/PR)
- HER2 status
- Other biomarkers specific to your cancer type
Questions to Ask Your Doctor
- What is my specific Ki-67 percentage, and what does that mean for my cancer?
- How does my Ki-67 result influence your treatment recommendations?
- Are there other markers you're considering alongside Ki-67 in my case?
This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.
This is general information.
Upload your records for guidance specific to YOUR diagnosis — personalized to your biomarkers, stage, and treatment history.
Related Services
Services that may help with diagnosis for cancer patients
Get guidance specific to your case
This answer covers general information. For guidance based on YOUR records, biomarkers, and treatment history:
Related Questions
Er+ oligomet breast cancer. Have been 5aking ribocyclib for 14 months. Because of my low neutrophils the dose was...
I appreciate you sharing these details about your treatment journey. Let me help you understand what's happening and what questions to bring to your o
What signs of progression should I watch for
Based on NCCN Guidelines for Myeloproliferative Neoplasms, here are the key warning signs you should monitor and report to your oncologist: Blood Co
What questions should I ask my oncologist at my next appointment
I'd love to help you prepare for your appointment! To give you the most relevant questions, it would help to know a bit more about your situation: 1.
What are treatment options for KRAS G12A and PIK3CA mutations in colorectal cancer
Thank you for the follow-up. I want to address something important that emerged from your medical profile: Your actual diagnosis is a fibroblastic/my
What are treatment options for KRAS G12A and PIK3CA mutations in colorectal cancer
I appreciate your question about these specific mutations. However, I want to first clarify something important about your medical profile: Your Situ